Compare Novartis AG (NVS) vs PubMatic Inc (PUBM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs PubMatic Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while PubMatic Inc trades at $13 (market cap $607.48M). The key difference: Novartis AG is far larger — about 477.8× PubMatic Inc's market cap, and Novartis AG pays a 3.17% dividend while PubMatic Inc pays none. Which is the better fit depends on your goals.
| NVS | PUBM | |
|---|---|---|
Market Cap | $290.25B | $607.48M |
Sector | Health | Technology |
52-Week High | $168.62 | $13.83 |
52-Week Low | $113.50 | $6.28 |
Enterprise Value | $330.27B | $504.98M |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About PubMatic Inc
PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.
Read more on PUBM →
